Survey of Ophthalmology
Volume 49, Issue 2, Supplement 1 , Pages S36-S44 , March 2004

A Cost-effectiveness comparison of bimatoprost versus latanoprost in patients with glaucoma or ocular hypertension

  • John G. Walt, MBA

      Affiliations

    • Corresponding Author InformationReprint address: John Walt, MBA, Global Pharmacoeconomic Strategy and Research, Allergan Inc, 2525 Dupont Drive, Irvine, CA, 92612-1599.
    • ,
  • Jeffrey T. Lee, PharmD, FCCP

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ These data were presented at the Annual Meeting of Managed Care Pharmacy; October 17–20, 2001; Dallas, TX. John Walt and Jeffrey Lee are employees of Allergan, Inc.

PII: S0039-6257(03)00193-0

doi: 10.1016/j.survophthal.2003.12.018

Survey of Ophthalmology
Volume 49, Issue 2, Supplement 1 , Pages S36-S44 , March 2004

Article Tools

* Image Usage & Resolution